Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2013 (2013), Article ID 379320, 5 pages
http://dx.doi.org/10.1155/2013/379320
Case Report

Fatal Disseminated Fusarium Infection in a Human Immunodeficiency Virus Positive Patient

Department of Pathology, Howard University Hospital, 2041 Georgia Avenue NW, Washington, DC 20060, USA

Received 14 March 2013; Accepted 23 April 2013

Academic Editors: M. Ghate, P. Horrocks, and E. M. Stringer

Copyright © 2013 Ashwini K. Esnakula et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Muhammed, J. J. Coleman, H. A. Carneiro, and E. Mylonakis, “The challenge of managing fusariosis,” Virulence, vol. 2, no. 2, pp. 91–96, 2011. View at Google Scholar · View at Scopus
  2. J. R. Perfect, “The impact of the host on fungal infections,” American Journal of Medicine, vol. 125, supplement 1, pp. S39–S51, 2012. View at Publisher · View at Google Scholar
  3. R. Galimberti, A. C. Torre, M. C. Baztan, and F. Rodriguez-Chiappetta, “Emerging systemic fungal infections,” Clinics in Dermatology, vol. 30, no. 6, pp. 633–650, 2012. View at Publisher · View at Google Scholar
  4. D. P. Short, K. O'Donnell, N. Zhang, J. H. Juba, and D. M. Geiser, “Widespread occurrence of diverse human pathogenic types of the fungus Fusarium detected in plumbing drains,” Journal of Clinical Microbiology, vol. 49, no. 12, pp. 4264–4272, 2011. View at Publisher · View at Google Scholar
  5. M. C. Dignani and E. Anaissie, “Human fusariosis,” Clinical Microbiology and Infection, vol. 10, supplement 1, pp. 67–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Nucci and E. Anaissie, “Fusarium infections in immunocompromised patients,” Clinical Microbiology Reviews, vol. 20, no. 4, pp. 695–704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Leal Jr., C. Vareechon, S. Cowden et al., “Fungal antioxidant pathways promote survival against neutrophils during infection,” The Journal of Clinical Investigation, vol. 122, no. 7, pp. 2482–2498, 2012. View at Publisher · View at Google Scholar
  8. M. Campo, R. E. Lewis, and D. P. Kontoyiannis, “Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009,” Journal of Infection, vol. 60, no. 5, pp. 331–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. J. Park, P. G. Pappas, K. A. Wannemuehler et al., “Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006,” Emerging Infectious Diseases, vol. 17, no. 10, pp. 1855–1864, 2011. View at Publisher · View at Google Scholar
  10. M. Nucci and E. Anaissie, “Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management,” Clinical Infectious Diseases, vol. 35, no. 8, pp. 909–920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Eljaschewitsch, J. Sandfort, K. Tintelnot, I. Horbach, and B. Ruf, “Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B,” Mycoses, vol. 39, no. 3-4, pp. 115–119, 1996. View at Google Scholar · View at Scopus
  12. J. Guarro, M. Nucci, T. Akiti, and J. Gene, “Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient,” Journal of Clinical Microbiology, vol. 38, no. 9, pp. 3460–3462, 2000. View at Google Scholar · View at Scopus
  13. N. Hadad, R. Levy, F. Schlaeffer, and K. Riesenberg, “Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition,” Clinical and Vaccine Immunology, vol. 14, no. 11, pp. 1515–1521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. de Marie, “Diseases and drug-related interventions affecting host defence,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 12, supplement 1, pp. S36–S41, 1993. View at Google Scholar
  15. D. Donati, D. Degiannis, L. Homer, L. Gastaldi, J. Raskova, and K. Raska, “Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release,” Nephron, vol. 58, no. 3, pp. 268–275, 1991. View at Google Scholar · View at Scopus
  16. P. M. Grant, L. Komarow, J. Andersen et al., “Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early versus deferred ART during an opportunistic infection,” PloS One, vol. 5, no. 7, Article ID e11416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. R. Klatt and J. M. Brenchley, “Th17 cell dynamics in HIV infection,” Current Opinion in HIV and AIDS, vol. 5, no. 2, pp. 135–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Sutton, A. W. Fothergill, and M. G. Rinaldi, Guide to Clinically Significant Fungi, Williams & Wilkins, Baltimore, Md, USA, 1st edition, 1998.
  19. D. Y. Ho, J. D. Lee, F. Rosso, and J. G. Montoya, “Treating disseminated fusariosis: amphotericin B, voriconazole or both?” Mycoses, vol. 50, no. 3, pp. 227–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Vagace, C. Sanz-Rodriguez, M. S. Casado et al., “Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report,” BMC Infectious Diseases, vol. 7, article 40, 2007. View at Publisher · View at Google Scholar · View at Scopus